← Signal Board

Neurocrine Biosciences financial statements

뉴로크린 바이오사이언시스NASDAQ:NBIX · Nasdaq · Healthcare · sector #17
$145.51+0.90%
2026-10-06 close

Neurocrine Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $2.36B. 2024 operating profit was $570M.

Reported results

Neurocrine Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy